Kestra Private Wealth Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-1,440
Closed -$279K – 1429
2024
Q3
$279K Sell
1,440
-1,952
-58% -$408K 0.01% 1109
2024
Q2
$786K Sell
3,392
-2,052
-38% -$446K 0.02% 656
2024
Q1
$1.17M Buy
5,444
+182
+3% +$42.6K 0.03% 513
2023
Q4
$1.36M Buy
+5,262
New +$1.29M 0.03% 442
2023
Q3
– Sell
-761
Closed -$217K – 1174
2023
Q2
$217K Buy
+761
New +$227K 0.01% 940
2022
Q4
– Sell
-839
Closed -$224K – 910
2022
Q3
$224K Buy
+839
New +$178K 0.01% 745
2022
Q2
– Sell
-1,169
Closed -$246K – 926
2022
Q1
$246K Sell
1,169
-7
-0.6% -$1.52K 0.01% 814
2021
Q4
$282K Buy
1,176
+33
+3% +$8.48K 0.01% 788
2021
Q3
$323K Sell
1,143
-632
-36% -$207K 0.02% 675
2021
Q2
$615K Sell
1,775
-522
-23% -$158K 0.04% 455
2021
Q1
$643K Sell
2,297
-33
-1% -$8.9K 0.04% 397
2020
Q4
$568K Sell
2,330
-806
-26% -$208K 0.04% 414
2020
Q3
$890K Buy
+3,136
New +$875K 0.08% 262

Other funds holding BIIB

Kestra Private Wealth Services's BIIB Position: Q4 2024 in Review

Kestra Private Wealth Services sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,440 shares — an estimated $279K sold.

Kestra Private Wealth Services first reported a position in BIIB in Q3 2020 and held it in 13 quarters. The position peaked at $1.36M in Q4 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Kestra Private Wealth Services reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Kestra Private Wealth Services sold 1,440 Biogen shares in Q4 2024, an estimated $279K.
  • Kestra Private Wealth Services first reported a position in Biogen in Q3 2020 and held it in 13 quarters.
  • Kestra Private Wealth Services's Biogen position peaked at $1.36M in Q4 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Kestra Private Wealth Services's 13F filing for Q4 2024, filed 28 Jan 2025.